Eiichiro Satake, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Nephropathies | 7 | 2022 | 984 | 1.120 |
Why?
|
| Kidney Failure, Chronic | 7 | 2022 | 2538 | 0.670 |
Why?
|
| Diabetes Mellitus, Type 1 | 6 | 2021 | 3336 | 0.650 |
Why?
|
| Inositol | 1 | 2016 | 218 | 0.510 |
Why?
|
| Glucose Tolerance Test | 2 | 2016 | 1150 | 0.450 |
Why?
|
| Hyperglycemia | 2 | 2021 | 1373 | 0.440 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2021 | 1632 | 0.370 |
Why?
|
| MicroRNAs | 3 | 2021 | 3752 | 0.350 |
Why?
|
| Body Fat Distribution | 1 | 2010 | 244 | 0.340 |
Why?
|
| Hypercalcemia | 2 | 2013 | 409 | 0.330 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2022 | 11725 | 0.310 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 2208 | 0.290 |
Why?
|
| Neuroblastoma | 2 | 2023 | 1226 | 0.250 |
Why?
|
| Receptors, Tumor Necrosis Factor | 3 | 2021 | 595 | 0.240 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2023 | 66 | 0.220 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2021 | 55 | 0.200 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2020 | 58 | 0.190 |
Why?
|
| Adipogenesis | 2 | 2013 | 359 | 0.180 |
Why?
|
| Albuminuria | 2 | 2020 | 682 | 0.170 |
Why?
|
| Focal Adhesions | 1 | 2018 | 121 | 0.150 |
Why?
|
| Telomere-Binding Proteins | 1 | 2018 | 116 | 0.150 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2018 | 209 | 0.140 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 804 | 0.140 |
Why?
|
| Disease Progression | 9 | 2023 | 13284 | 0.130 |
Why?
|
| Kidney | 5 | 2023 | 7186 | 0.130 |
Why?
|
| Nerve Growth Factors | 1 | 2018 | 574 | 0.130 |
Why?
|
| Japan | 2 | 2016 | 1360 | 0.120 |
Why?
|
| Adaptor Protein Complex sigma Subunits | 1 | 2013 | 9 | 0.120 |
Why?
|
| Waist Circumference | 2 | 2015 | 917 | 0.120 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 2013 | 43 | 0.120 |
Why?
|
| Glomerular Filtration Rate | 4 | 2023 | 2170 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 783 | 0.110 |
Why?
|
| Carbenoxolone | 1 | 2011 | 10 | 0.110 |
Why?
|
| Proteinuria | 1 | 2015 | 658 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 644 | 0.100 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 3462 | 0.090 |
Why?
|
| Cholecystokinin | 1 | 2011 | 114 | 0.090 |
Why?
|
| Calcium, Dietary | 1 | 2013 | 526 | 0.090 |
Why?
|
| Lipids | 2 | 2013 | 3305 | 0.090 |
Why?
|
| Peptide YY | 1 | 2011 | 130 | 0.090 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2010 | 65 | 0.090 |
Why?
|
| Hyperphagia | 1 | 2011 | 136 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2021 | 3002 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 4420 | 0.090 |
Why?
|
| Adipocytes | 2 | 2013 | 1184 | 0.080 |
Why?
|
| Models, Theoretical | 1 | 2021 | 3589 | 0.080 |
Why?
|
| Glucocorticoids | 2 | 2010 | 2107 | 0.080 |
Why?
|
| Ghrelin | 1 | 2011 | 266 | 0.080 |
Why?
|
| Intra-Abdominal Fat | 2 | 2011 | 591 | 0.080 |
Why?
|
| Abdominal Fat | 1 | 2010 | 223 | 0.080 |
Why?
|
| Milk, Human | 1 | 2013 | 490 | 0.080 |
Why?
|
| Proteomics | 4 | 2022 | 3638 | 0.080 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 361 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2021 | 4217 | 0.080 |
Why?
|
| Fetal Growth Retardation | 1 | 2011 | 570 | 0.070 |
Why?
|
| Humans | 23 | 2023 | 744343 | 0.070 |
Why?
|
| Furosemide | 1 | 2006 | 167 | 0.070 |
Why?
|
| Male | 14 | 2021 | 350118 | 0.070 |
Why?
|
| Female | 16 | 2021 | 380194 | 0.070 |
Why?
|
| Adult | 10 | 2021 | 214055 | 0.060 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2010 | 546 | 0.060 |
Why?
|
| Fibrosis | 2 | 2023 | 2029 | 0.060 |
Why?
|
| Calcitonin | 1 | 2006 | 336 | 0.060 |
Why?
|
| Gastrointestinal Tract | 1 | 2011 | 814 | 0.060 |
Why?
|
| Williams Syndrome | 1 | 2006 | 187 | 0.060 |
Why?
|
| Sodium Chloride | 1 | 2006 | 625 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2018 | 6256 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2011 | 1889 | 0.060 |
Why?
|
| Dietary Fats | 1 | 2010 | 2017 | 0.050 |
Why?
|
| Middle Aged | 7 | 2021 | 213383 | 0.050 |
Why?
|
| Endostatins | 1 | 2022 | 174 | 0.050 |
Why?
|
| Infant Formula | 2 | 2013 | 199 | 0.050 |
Why?
|
| Inflammation | 1 | 2021 | 10638 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 40561 | 0.050 |
Why?
|
| Prognosis | 4 | 2020 | 29063 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2010 | 2585 | 0.040 |
Why?
|
| Mass Screening | 1 | 2015 | 5255 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2011 | 3279 | 0.040 |
Why?
|
| Glucose | 1 | 2011 | 4397 | 0.040 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2021 | 416 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2022 | 588 | 0.040 |
Why?
|
| Child | 4 | 2016 | 77709 | 0.040 |
Why?
|
| Ductus Arteriosus | 1 | 2018 | 39 | 0.040 |
Why?
|
| Age Factors | 2 | 2015 | 18370 | 0.040 |
Why?
|
| New England | 1 | 2020 | 1022 | 0.040 |
Why?
|
| Animals | 6 | 2021 | 168757 | 0.040 |
Why?
|
| Body Weight | 3 | 2011 | 4669 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2011 | 2726 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2018 | 23403 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2021 | 1026 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 2007 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2019 | 1124 | 0.030 |
Why?
|
| Gene Expression | 2 | 2021 | 7799 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2013 | 34 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2013 | 103 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2013 | 198 | 0.030 |
Why?
|
| Infant | 3 | 2013 | 35136 | 0.030 |
Why?
|
| Vitamin D | 1 | 2006 | 3223 | 0.030 |
Why?
|
| Risk Factors | 4 | 2021 | 72290 | 0.020 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenases | 1 | 2010 | 6 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 12959 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2021 | 21746 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2021 | 4161 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 1889 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2011 | 212 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2011 | 8301 | 0.020 |
Why?
|
| Mutation | 1 | 2013 | 29786 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 1791 | 0.020 |
Why?
|
| Adolescent | 3 | 2011 | 85781 | 0.020 |
Why?
|
| Triglycerides | 1 | 2015 | 2454 | 0.020 |
Why?
|
| Insulin | 2 | 2013 | 6580 | 0.020 |
Why?
|
| Biological Transport | 1 | 2011 | 2118 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12788 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 2252 | 0.020 |
Why?
|
| Child Development | 1 | 2018 | 2223 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2011 | 952 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2013 | 1951 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2021 | 6544 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 15165 | 0.020 |
Why?
|
| Mice | 3 | 2021 | 81183 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 13989 | 0.020 |
Why?
|
| Rats | 2 | 2011 | 24260 | 0.010 |
Why?
|
| Eating | 1 | 2011 | 1536 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 6386 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2019 | 53288 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10397 | 0.010 |
Why?
|
| Body Composition | 1 | 2011 | 2401 | 0.010 |
Why?
|
| Logistic Models | 1 | 2015 | 13408 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2015 | 8554 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 3617 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2011 | 3188 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2018 | 25625 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2011 | 5985 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 13033 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 25043 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2011 | 12720 | 0.010 |
Why?
|
| Aged | 2 | 2019 | 163280 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 77449 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18029 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 63114 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 57776 | 0.000 |
Why?
|
| Young Adult | 1 | 2010 | 56430 | 0.000 |
Why?
|